Holen Sie sich die Stockscreener-App
12.18
3.13%
0.3693
Compass Pathways Plc Adr Aktie (CMPS) Neueste Nachrichten
COMPASS Pathways Plc Q1 2026 Earnings: Narrower Loss Provides Hope Amid Pre-Revenue StageLow Growth Earnings - Newser
CMPS Stock Quote Price and Forecast - CNN
Compass Pathways stock hits 52-week high at 11.65 USD - Investing.com
Compass Pathways Eyes Q4 FDA Filing for Psilocybin Depression Drug After Phase 3 Wins - Barchart.com
Why LiveRamp Shares Are Trading Higher By Over 26%; Here Are 20 Stocks Moving Premarket - Sahm
Is Compass Pathways (CMPS) outperforming other medical stocks this year? - MSN
Compass Pathways Reports Strong Q1 Results, Shares Surge - Sahm
Why COMPASS Pathways (CMPS) Is Up 13.1% After FDA Fast-Track Moves For COMP360 Profit Shift - Sahm
Compass Pathways stock hits 52-week high at 10.22 USD - Investing.com India
Compass Pathways Q1 Earnings Call Highlights - Barchart.com
Compass Pathways stock surges 8% on beating estimates as FDA accelerates review - Investing.com India
Compass Pathways stock surges 8% on beating estimates as FDA accelerates review By Investing.com - Investing.com South Africa
Compass Pathways Announces First Quarter 2026 Financial Results and Business Highlights - Via TT
What makes COMPASS Pathways PLC sponsored ADR (CMPS) a strong momentum stock: Buy now? - MSN
How much upside is left in COMPASS Pathways (CMPS)? Wall Street analysts think 136% - MSN
Compass Pathways earnings on deck as psychedelic approval nears By Investing.com - Investing.com South Africa
Compass Pathways earnings on deck as psychedelic approval nears - Investing.com
Compass Pathways PLC Sponsored ADR (NASDAQ:CMPS) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
These 3 Psychedelic Stocks Activated After Trump's Executive Order - MarketBeat
CMPS Stock Price, Quote & Chart | COMPASS PATHWAYS PLC (NASDAQ:CMPS) - ChartMill
BIT Capital GmbH Raises Stock Holdings in Compass Pathways PLC Sponsored ADR $CMPS - MarketBeat
This AMD Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Sahm
Trump Wants to Give Psychedelics Stocks a Boost. Can This Leading Company Deliver? - Barchart
Error: Response status code does not indicate success: 503 (Service Unavailable). - Yahoo Finance
These 3 Psychedelic Stocks Activated After Trump’s Executive Order - Investing.com
This Walker & Dunlop Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Sahm
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher - Investing.com India
Compass Pathways stock gets Morgan Stanley overweight rating on FDA voucher By Investing.com - Investing.com South Africa
Compass Pathways (NASDAQ:CMPS) Sees Large Volume IncreaseHere's Why - MarketBeat
Compass Pathways shares rise as FDA grants rolling review for depression drug By Investing.com - Investing.com South Africa
FDA grants priority voucher to Compass for psilocybin treatment By Investing.com - Investing.com India
FDA grants priority voucher to Compass for psilocybin treatment - Investing.com
Compass Pathways shares rise as FDA grants rolling review for depression drug - Investing.com
Is COMPASS Pathways (CMPS) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Compass Pathways (NASDAQ:CMPS) Stock Price Up 7.7%Here's What Happened - MarketBeat
0.10%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):